{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:45:01Z","timestamp":1767861901658,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":782,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jtct.2020.11.008","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T22:04:35Z","timestamp":1617746675000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia"],"prefix":"10.1016","volume":"27","author":[{"given":"Leland","family":"Metheny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Politikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Ballen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Milano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet N.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio G.","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2020.11.008_bib0001","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbmt.2014.10.030","article-title":"Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type","volume":"21","author":"Warlick","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0002","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0003","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy","volume":"26","author":"Kanate","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0004","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2002.v8.pm12064362","article-title":"Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow","volume":"8","author":"Barker","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2020.11.008_bib0006","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the US registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2020.11.008_bib0007","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2020.11.008_bib0008","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1182\/bloodadvances.2020003371","article-title":"High progression-free survival after intermediate intensity double unit cord blood transplantation in adults","volume":"4","author":"Barker","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2020.11.008_bib0009","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/bloodadvances.2020001554","article-title":"Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant","volume":"4","author":"Sharma","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2020.11.008_bib0010","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1158\/1078-0432.CCR-17-3622","article-title":"Impact of donor type in patients with AML given allogeneic hematopoietic cell transplantation after low-dose TBI-based regimen","volume":"24","author":"Baron","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2020.11.008_bib0011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/bmt.2016.182","article-title":"Clinical separation of cGvHD and GvL and better GvHD-free\/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML","volume":"52","author":"Zheng","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0012","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3324\/haematol.2018.202754","article-title":"Disability related to chronic graft-versus-host disease after alternative donor hematopoietic cell transplantation","volume":"104","author":"Fatobene","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.008_bib0013","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1002\/ajh.24340","article-title":"Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older","volume":"91","author":"Konuma","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0014","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbmt.2013.06.006","article-title":"Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia","volume":"19","author":"Peffault de Latour","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbmt.2014.11.685","article-title":"Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years","volume":"21","author":"Tanaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0016","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbmt.2019.12.768","article-title":"Incidence and risk factors for acute and chronic kidney injury after adult cord blood transplantation","volume":"26","author":"Gutgarts","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0017","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2002-11-3337","article-title":"Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning","volume":"102","author":"Barker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0018","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bbmt.2020.05.018","article-title":"Splenomegaly negatively impacts neutrophil engraftment in cord blood transplantation","volume":"26","author":"Yuasa","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bjh.13136","article-title":"Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia","volume":"168","author":"Barker","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0020","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0021","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2020.11.008_bib0022","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101)","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0023","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.24613","article-title":"Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation","volume":"92","author":"Nakasone","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0024","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2009-09-244145","article-title":"Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis","volume":"115","author":"Brown","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0025","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","article-title":"Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation","volume":"108","author":"Brunstein","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0026","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/bmt.2014.216","article-title":"Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies","volume":"50","author":"Pascal","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0028","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbmt.2019.11.016","article-title":"Unlicensed umbilical cord blood units provide a safe and effective graft source for a diverse population: a study of 2456 umbilical cord blood recipients","volume":"26","author":"Ballen","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0029","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2014-09-599241","article-title":"Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation","volume":"126","author":"Pascal","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/bloodadvances.2019000836","article-title":"Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin","volume":"4","author":"Politikos","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2020.11.008_bib0031","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbmt.2013.02.007","article-title":"A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation","volume":"19","author":"Ponce","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0032","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41409-019-0715-x","article-title":"A phase II study of reduced-intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low-dose total body irradiation","volume":"55","author":"DeFilipp","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0033","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood.V122.21.697.697","article-title":"Umbilical cord blood transplant patients at high risk of graft rejection achieve early full donor chimerism when 300 cGy is used in the reduced intensity conditioning regimen","volume":"122","author":"Salit","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0034","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbmt.2017.11.020","article-title":"Antithymocyte globulin: steps toward individualized dosing","volume":"24","author":"Admiraal","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0036","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0037","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/bjh.14962","article-title":"Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies","volume":"179","author":"Paviglianiti","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0038","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0039","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0040","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1200\/JCO.2016.70.7349","article-title":"Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC trial)","volume":"35","author":"Kr\u00f6ger","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2020.11.008_bib0041","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood.V128.22.4693.4693","article-title":"Myeloablative cord blood transplantation yields excellent disease free survival in patients with acute lymphoblastic leukemia","volume":"128","author":"Oliver","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0042","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2018.10.016","article-title":"Single-unit versus double-unit umbilical cord blood transplantation in children and young adults with residual leukemic disease","volume":"25","author":"Balligand","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0043","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bbmt.2017.01.084","article-title":"Prognostic value of the Hematopoietic Cell Transplantation Comorbidity Index for patients undergoing reduced-intensity conditioning cord blood transplantation","volume":"23","author":"Salit","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0044","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2018.02.013","article-title":"Promising outcome of umbilical cord blood transplantation in patients with multiple comorbidities","volume":"24","author":"Adachi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0045","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bbmt.2013.09.015","article-title":"Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms","volume":"19","author":"Sanz","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0046","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2012.13","article-title":"Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen","volume":"47","author":"Sanz","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0047","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbmt.2010.09.009","article-title":"Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning","volume":"17","author":"Kanda","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0048","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.bbmt.2017.06.027","article-title":"Adult umbilical cord blood transplantation using myeloablative thiotepa, total body irradiation, and fludarabine conditioning","volume":"23","author":"Anand","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0049","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2018.04.019","volume":"24","author":"Sharma","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0050","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/bloodadvances.2020002222","article-title":"Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study","volume":"4","author":"Milano","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2020.11.008_bib0051","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clml.2013.08.006","article-title":"The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation","volume":"14","author":"Mehta","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2020.11.008_bib0052","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbmt.2008.02.016","article-title":"Myeloablative intravenous busulfan\/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients","volume":"14","author":"Horwitz","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0053","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.bbmt.2016.06.017","article-title":"A novel reduced-toxicity myeloablative conditioning regimen using full-dose busulfan, fludarabine, and melphalan for single cord blood transplantation provides durable engraftment and remission in nonremission myeloid malignancies","volume":"22","author":"Yamamoto","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0054","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.bbmt.2014.07.014","article-title":"Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation","volume":"20","author":"Abedin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bmt.2010.192","article-title":"Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis","volume":"46","author":"Cutler","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0056","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity umbilical cord blood transplantation in adults","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.008_bib0057","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3324\/haematol.2014.106690","article-title":"Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced-intensity conditioning: results of the HOVON 106 phase II study","volume":"99","author":"Somers","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.008_bib0058","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/HS9.0000000000000285","article-title":"Double umbilical cord blood transplantation in high-risk hematological patients: a phase II study focusing on the mechanism of graft predominance","volume":"3","author":"Kalin","year":"2019","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtct.2020.11.008_bib0059","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/blood-2018-01-829630","article-title":"Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study","volume":"132","author":"Peffault de Latour","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.008_bib0060","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:00:43Z","timestamp":1763002843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636720300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2666636720300051"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.008","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}